Grey Wolf Health (TSXV:WOLF) ROCE %: 4.86% (As of Mar. 2026)


TSXV:WOLF Grey Wolf Health Corp TSXV:WOLF
57 GF Score
Price C$1.75
GF Value C$1.10
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Grey Wolf Health ROCE %?

Grey Wolf Health TSXV:WOLF 57 ROCE % is 4.86% as of Mar. 2026. GuruFocus rates TSXV:WOLF with a GF Score™ of 57/100 and a GF Value™ of C$1.10 (Significantly Overvalued). The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Grey Wolf Health's annualized ROCE % for the quarter that ended in Mar. 2026 was 4.86%.

Grey Wolf Health  (TSXV:WOLF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Grey Wolf Health ROCE % Related Terms

Grey Wolf Health ROCE % Historical Data

* Premium members only.

The historical data trend for Grey Wolf Health's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Grey Wolf Health ROCE % Chart

Grey Wolf Health Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
-1.41 33.03 4.83 4.31 7.05

Grey Wolf Health Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.68 10.29 8.41 5.85 4.86
TSXV:WOLF
57GF Score
Grey Wolf Health Corp TSXV:WOLF
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Grey Wolf Health ROCE % Calculation

Grey Wolf Health's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=4.151/( ( (65.602 - 6.175) + (64.528 - 6.209) )/ 2 )
=4.151/( (59.427+58.319)/ 2 )
=4.151/58.873
=7.05 %

Grey Wolf Health's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=2.828/( ( (64.528 - 6.209) + (64.364 - 6.305) )/ 2 )
=2.828/( ( 58.319 + 58.059 )/ 2 )
=2.828/58.189
=4.86 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 4.86% mean?
Grey Wolf Health (TSXV:WOLF) has a ROCE % of 4.86% as of Mar. 2026.
Is Grey Wolf Health's ROCE % too high?
Grey Wolf Health's current ROCE % is 4.86%. The Personal Services industry median ROCE % is 6.08. Grey Wolf Health's value of 4.86% is 20.1% below this industry median. Overall, Grey Wolf Health has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Grey Wolf Health's ROCE % compare to ROL and SCI?
Grey Wolf Health's ROCE % of 4.86% can be compared against companies in the Personal Services industry. The industry median ROCE % is 6.08. Grey Wolf Health's value of 4.86% is 20.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Personal Services company?
The median ROCE % among Personal Services companies is 6.08, based on 95 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Grey Wolf Health's current ROCE % of 4.86% is 20.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Personal Services industry, the median ROCE % is 6.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Grey Wolf Health's current ROCE % is 4.86%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grey Wolf Health stock overvalued right now?
Based on GuruFocus' analysis, Grey Wolf Health (TSXV:WOLF) is currently considered Significantly Overvalued. The stock's GF Value™ is C$1.10, compared to a current price of C$1.75 — trading 59.1% above its estimated fair value. The current ROCE % is 4.86% and 20.1% below the Personal Services industry median of 6.08. Grey Wolf Health's overall GF Score™ is 57/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Grey Wolf Health (TSXV:WOLF), the current ROCE % is 4.86% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Grey Wolf Health (TSXV:WOLF) Overvalued in 2026?

Based on GuruFocus' analysis, Grey Wolf Health stock appears to be overvalued. The current stock price of C$1.75 is trading 59.1% above its estimated GF Value™ of C$1.10. GuruFocus considers Grey Wolf Health to be Significantly Overvalued.

Key valuation signals for TSXV:WOLF:

  • ROCE %: 4.86%
  • GF Value™: C$1.10 vs. price of C$1.75 (59.1% above fair value)
  • GF Score™: 57/100 with 5 warning signs
  • Industry Position: 20.1% below the Personal Services median

No single metric tells the full story. See the TSXV:WOLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Grey Wolf Health Business Description

Address 100 King Street West, Suite 6000, 1 First Canadian Place, Toronto, ON, CAN, M5X 1E2
Grey Wolf Animal Health Corp focuses on sourcing, in-licensing, acquiring, and compounding branded and generic products for sale in both animal and human health markets in Canada. The Company operates through two reportable segments: the Animal Health segment, which involves the sale, marketing, and distribution of pharmaceutical, nutraceutical, and consumable products to veterinary clinics across Canada; and the Pharmacy segment, which generates the majority of revenue and focuses on compounding pharmaceuticals for both human and animal health markets.
57GF Score

Get the complete analysis for TSXV:WOLF

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$1.75
Price
C$1.10
GF Value